Embed Size (px)
Citation preview
Italian and European experiences come across: IBD and beyond
Turin 23-24 September 2016
Turin
23-
24 S
epte
mbe
r 201
6
2 3
RATIONALEInflammatory bowel diseases (IBDs) are not only a clinical issue, but also an epidemiological and management issue, which often overcomes the field of Gastroenterology itself. Different health care practicioners with specific profiles are needed to solve different and peculiar problems that patients are facing.
This international meeting approaches this year its fourth biennial edition, and it is focused to clarify many of these issues through the involvement of international key opinion leaders and of Italian and international IBD expert physicians. Previous editions were based on the comparison between Italy and Belgium (2010), France (2012) and Easter European Countries (2014). This year the comparison will be with Danish and German colleagues.
Based on the limited number of the attendees (120 partecipats maximum), the meeting is aimed to favour occasions of contact and networking with national and international key opinion leaders which may hopefully persist well after the meeting itself.
We’re looking forward to seeing you in Torino for the meeting!
RATIONALELe malattie infiammatorie croniche (IBD) non sono solo un problema clinico, ma anche epidemiologico e gestionale che trascende costantemente il campo della ‘semplice’ Gastroenterologia, richiedendo spesso il coinvolgimento di diverse figure professionali per la gestione delle molteplici problematiche che interessano il paziente.
Il meeting internazionale, giunto quest’anno alla sua quarta edizione con cadenza biennale, mira ad approfondire molti di questi aspetti coinvolgendo esperti internazionali e platee di specialisti che si dedicano alla gestione di queste malattie in Italia e all’estero. Le precedenti edizioni hanno consentito di sviluppare il confronto con il Belgio (2010), la Francia (2012), i Paesi dell’Europa Orientale (2014). In questa edizione il confronto avverrà con i colleghi Danesi e Tedeschi.
L’organizzazione del meeting è volta a favorire, grazie alle numeriche limitate dei partecipanti (120 discenti al massimo), un contatto con i maggiori esperti nazionali e internazionali, anche allo scopo di favorire un’attività di networking che possa durare al di fuori ed al di là dell’evento stesso.
Ci auguriamo di potervi trovare a Torino per il meeting!
Turin
23-
24 S
epte
mbe
r 201
6
4 5
Second SessionHow deep should we assess IBD? Chair: F. Castiglione
14.00-14.20 The role of a common language in US: the IG-IBD Imaging project in Italy
E. Calabrese
14.20-14.40 The role of a common language in endoscopy: the IG-IBD Endo project in Italy
M. Comberlato
14.40-15.00 Beyond the scope: endomicroscopy and new endoscopic techniques
G.E. Tontini
15.00-15.20 The role of Pathologists in IBD: diagnosis, activity and dysplasia
V. Villanacci
15.20-15.40 What can you ask to MRI for inflammatory bowel disease?
M. Petracchini
15.40-16.10 General Discussion
16.10-16.40 Coffee Break
EXTRA CME SESSION16.40-17.10 LECTURE Vedolizumab: bridging the future M. Daperno
Friday September 23rd 2016First SessionIBD Epidemiology: many answers and many open questionsChair: V. Annese
10.00-10.15 Welcome and meeting structure overview
R. Rocca
10.15-10.35 IBD epidemiology in Italy: what we know and what we still have to explore
A. Kohn
10.35-11.05 IBD epidemiology in Denmark: the Danish IBD registry and results on cancer, mortality and long-term treatment effects issues in IBD
E. Langholz
11.05-11.25 Cancer and IBD, an Italian experience L. Biancone
11.25-11.45 How to build-up a solid epidemiologic study: the experience of ECCO-Epicom cohort
N. Pedersen
11.45-12.05 General discussion
EXTRA CME SESSION12.05-12.35 LECTURE Efficacy and Safety of Adalimumab
in Ulcerative Colitis G. Fiorino
12.35-14.00 Lunch break
Turin
23-
24 S
epte
mbe
r 201
6
6 7
Saturday September 24th, 2016Fourth SessionEscalating disease treatments: best strategies for clinical practice Chair: C. Papi
08.30-08.50 What is refractoriness? A user-guide for clinical practice
A. Armuzzi
08.50-09.10 Patient profiling for biologic treatments P. Gionchetti
09.10-09.30 Real life experience with s.c. anti-TNF in Italy
M. Daperno
09.30-09.50 Real life experience with vedolizumab in Germany
D.C. Baumgart
09.50-10.10 Safety of biologics in the year 2016 A. Orlando
10.10-10.30 Danish data on long-term safety issues with anti-TNF agents
I. Vind
10.30-10.50 Traditional treatments in the “accelerated step-up” paradigm in Germany: how use them
U. Helwig
10.50-11.20 General discussion
11.20-11.50 Coffee break
Friday September 23rd 2016Third SessionAre we obtaining enough from traditional treatments? Chair: S. Ardizzone
17.10-17.30 Are all mesalamine the same? M. Vecchi
17.30-17.50 The use of eHealth to optimize mesalamine use
N. Pedersen
17.50-18.10 Don’t forget: why and when an Ophtalmologistist should kick in
E. Miserocchi
18.10-18.30 Don’t forget: why and when a Rheumatologist should kick in
R. Pellerito
18.30-18.50 Don’t forget: why and when a Dermatologist should kick in
P. Dapavo
18.50-19.20 General discussion
Turin
23-
24 S
epte
mbe
r 201
6
8
Saturday September 24th, 2016Fifth SessionFertility, pregnancy and miscellanea Chair: R. Rocca
11.50-12.10 Pregnancy and IBD: what do we know today?
A. Bortoli
12.10-12.30 Fertility in IBD: what should our patients know?
M. Julsgaard Nielsen
12.30-12.50 Is therapeutic drug monitoring becoming a real standard of practice in IBD?
R. D’Incà
12.50-13.10 IG-IBD registries results: an interim analysis on evolving projects
F. Rizzello
13.10-13.50 General Discussion
13.50-14.00 CME testing
SCIENTIFIC & GENERAL
INFORMATION
Turin
23-
24 S
epte
mbe
r 201
6
10 11
GENERAL INFORMATIONVENUENH Santo StefanoVia Porta Palatina, 1910122 Torino
LANGUAGEEnglish is the official language of the Congress.
REGISTRATION Registration Fee € 366,00 (VAT 22% included)The Congress registration fee includes the final program, the certificate of attendance, the admission to the scientific sessions, coffee breaks and lunches during breaks
CME- CONTINUING MEDICAL EDUCATIONThe Congress will be accredited with the CME Italian system from the Provider PLS Educational for the categories of Medical Professionals in Gastroenterology, Pathological Anatomy, General Surgery and Internal Medicine
PRESIDENTA.Pera
SCIENTIFIC SECRETARYR. RoccaM. Daperno
SCIENTIFIC COORDINATORDaperno Marco, Turin (Italy)
FACULTYAnnese Vito, Florence (Italy)Ardizzone Sandro, Milan (Italy)Armuzzi Alessandro, Rome (Italy)Baumgart Daniel, Berlin (Germany)Biancone Livia, Rome (Italy)Bortoli Aurora, Milan (Italy)Calabrese Emma, Rome (Italy)Castiglione Fabiana, Naples (Italy)Comberlato Michele, Bolzano (Italy)Dapavo Paolo, Turin (Italy)D’Incà Renata, Padoa (Italy)Fiorino Gionata, Milan (Italy)Gionchetti Paolo, Bologna (Italy)Helwing Ulf, Kiel (Germany)Julsgaard Nielsen Mette, Aarhus C (Denmark)Kohn Anna, Rome (Italy)Langholz Ebbe, Hellerup (Denmark)Miserocchi Elisabetta, Turin (Italy)Orlando Ambrogio, Palermo (Italy)Papi Claudio, Rome (Italy)Pedersen Natalia, Herlev (Denmark)Pellerito Raffaele, Turin (Italy)Petracchini Massimo, Turin (Italy)Rizzello Fernando, Bologna (Italy)Rocca Rodolfo, Turin (Italy)Tontini Gian Eugenio, Milan (Italy)Vecchi Maurizio, Milan (Italy)Villanacci Vincenzo, Brescia (Italy)Vind Ida, Hvidovre (Denmark)
ORGANIZING SECRETARY
PLS EducationalFlorence, ITALY
UNDER THE AEGIS OF
THE SCIENTIFIC SECRETARY WANTS TO EXPRESS ITS HEARTFELT THANKS TO ALL THE SPONSORS FOR THEIR EDUCATIONAL
AND NO-CONDITIONING CONTRIBUTION FOR THE CONGRESS REALIZATION
CHIESI FARMACEUTICI
www.maki-adv.it
